QIAGEN CLC Genomics
Circulating Tumor Cell Detection and Analysis to Support Malignancy Designation, Tumor-of-Origin Identification, and Treatment Selection
63 views
In this seminar, you’ll learn:
From Helena Silva Cascales, senior scientist at iCellate Medical AB, how the isolation of whole-tumor cells provides a more comprehensive biomarker analysis, including genomic sequencing and multiplexed protein expression analysis.
From Kashyap Dave, principal scientist at iCellate Medical AB, how DNA from single CTCs can be amplified, sequenced, and analyzed to support malignancy designation and tissue of origin identification using classification analyses under development within Qiagen CLC Genomics Workbench.
Related videos
QIAGEN CLC Genomics
Part I: Single-cell RNA sequencing data analysis using QIAGEN CLC Genomics Workbench
This two-part series will walk you through single-cell RNA sequencing...
QIAGEN CLC Genomics
Immune repertoire analysis using QIAGEN CLC Genomics Workbench
The composition of the immune repertoire, consisting of the T cell and B...
QIAGEN CLC Genomics
Pathogen detection in wastewater samples using QIAGEN CLC Genomics Workbench
In this 90-minute training, you will learn how to easily analyze wastewater...
QIAGEN CLC Genomics
What’s new in QIAGEN CLC Genomics Workbench version 23
QIAGEN CLC Genomics Workbench version 23 is here with exciting updates we'd...